In today’s briefing:
- Pre-IPO Shanghai Pulse Medical Technology – The Industry, the Business and the Concerns
Pre-IPO Shanghai Pulse Medical Technology – The Industry, the Business and the Concerns
- The products of Shanghai Pulse Medical Technology (PMT HK) have entered the commercialization stage, indicating that the Company has gone through the stage from 0 to 1.
- The medical insurance coverage and CE Mark offer Pulse more options in terms of commercialization, which is very vital especially in front of domestic policy risk and unfriendly financing environment.
- Next, Pulse needs to focus more on how to increase the market penetration, so as to present promising commercialization results. Overall, we are looking forward to the future of Pulse.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
